Background {#Sec1}
==========

Penile squamous cell carcinoma has a low incidence among all cancers, according to the report there are 26,000 new cases occurring worldwide annually \[[@CR1]\]. However, in developing countries such as Africa, Asia, South America, etc. penile cancer is still a difficult problem, where its incidence varies from 3 to 8.3 cases per 100,000 \[[@CR2]\], especially in southwestern of China. The management of the regional lymph nodes is extremely important for long-term survival of the patient according to the National Comprehensive Cancer Network (NCCN) and the European Association of Urology (EAU) clinical practice guidelines. Both guidelines subdivide penile cancer into three groups of low risk, intermediate risk and high risk. Low-risk patients with non-palpable inguinal lymph node (cN0) can be managed by surveillance or dynamic sentinel node biopsy (DSNB), however, due to earlier Inguinal Lymph Node Dissection (ILND) surgery has a better prognosis than ILND after local lymph node recurrence, the indications for ILND recommended by the guidelines are do the operation as long as the inguinal lymph node are palpable, whether it is low-risk, moderate or high risk \[[@CR3]\]. However intermediate-risk patients with clinically non-palpable inguinal lymph nodes, only about 30% of them are able to detect micro-metastases after ILND. That means the rest of patients approximately 70% have no benefit from ILND and suffered from the complications of surgery. So it is crucial to selected the patients who are really benefits from ILND before surgery. Because prognosis of PSCC is highly correlated with lymph nodes stage, plenty of articles have select patients through the prognostic role of biomarkers. The major prognostic factors in PSCC are perineural invasion, pathological subtype, depth of invasion, grade and lymphovascular invasion \[[@CR4], [@CR5]\]. These factors are hard to precisely obtain before the operation. Besides some articles used biomarkers such as p53 and squamous cell carcinoma antigen to predict inguinal lymph node positive rate and prognosis of penile cancer, but they were not applied to clinical practice \[[@CR6], [@CR7]\]. So we hope to find some markers that is associated with inguinal lymph nodes metastatic or can predict the outcomes.

As we known that systemic inflammatory factors play an significant role in cancer progression \[[@CR8], [@CR9]\]. The tumor micro-environment regulated by inflammatory cells is clearly related to cancer progression \[[@CR8]\]. Systemic inflammatory factors are obviously reflected by changes of peripheral leukocyte, lymphocytes,neutrophils, monocytes and platelets. These factors above mentioned can reflect the tumor micro environment indirectly \[[@CR8]\], so we collected the data of peripheral blood parameters including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR) which have been reported to be independent prognostic factors in various of cancers \[[@CR8], [@CR10]--[@CR14]\]. Besides, high lactate dehydrogenase (LDH) has also shown that associated with poor OS in urologic cancer \[[@CR15]\].

Recently it has been reported that cancer patients with high NLR is associated with worse OS \[[@CR16]\] and worse RFS and CSS \[[@CR17], [@CR18]\]. However, there has been no study evaluating the PLR associated with outcomes of penile cancer. In this retrospective study, we investigated the role of NLR, LMR, PLR and LDH before surgery to predicting whether micro-metastases of inguinal lymph node exist and assessed the prognostic value in penile cancer.

Methods {#Sec2}
=======

We reviewed our electronic medical records system to identify men treated for penile SCC at Yunnan cancer hospital in China between October 2002 and December 2017. Experimental procedures were approved by the Human Ethics Committee of Yunnan Cancer Hospital.A total of 349 consecutive patients treated with ILND in PSCC, 225 was succeed to follow-up, Epidemiological and clinical data, including age, preoperative full blood count results NLR, LMR, PLR LDH and TNM clinical staging, tumor pathology, treatment history and oncological outcome (OS, PFS). Survival analysis was performed by the Kaplan--Meier method for univariable analysis and Cox regression method for multivariable analysis. The NLR was calculated by neutrophil-to-lymphocyte ratio, LMR was lymphocyte-to-monocyte ratio and PLR was platelet-to lymphocyte ratio which were obtained through peripheral complete blood count and blood biochemistry before the surgery. We calculate the cut-off point of the Ages, NLR, LMR, PLR and LDH according to the area under curve (AUC) given consideration to sensitivity and specificity levels.

The primary end point were overall survival (OS) and progression free survival (PFS) which defined as the time from the dates of pathological diagnosis to death and tumor progression. Univariable analysis (K-M analysis) was performed to compare the higher and lower groups of NLR, LMR, PLR and LDH. Multivariable analysis (COX logistic regression) were used to verify the individual factors respectively. *P* values less than 0.05 were considered statistical significance.

We also analyse the relation between the NLR, LMR, PLR, LDH and N stage through the logistic regression, meantime we use method of Kendall's tau-b correlation coefficient to determine the correlation.

Results {#Sec3}
=======

NLR, LMR, PLR, LDH vs OS/PFS {#Sec4}
----------------------------

A total of 225 patients had collected peripheral complete blood count and blood biochemistry before surgery. The mean (±SD) ages were 50.6 ± 13.4. The detailed data of patients are summarized in Table [1](#Tab1){ref-type="table"}. We performed AUC curve to determine the Age, NLR, LMR, PLR and LDH cut-off value which were 53,2.94,4.74,133.5 and 188.5 respectively. The median interquartile range follow-up was 30 (16.0--63.5) months. Among the 225 patients, 171 was survival which the median interquartile range follow-up was 34 (18.0--84.0) months; 150 was disease free which the median interquartile range follow-up was 33 (18.0--85.25) months; 29 was alive with disease progression,8 was dead of other causes. Table 1Patients' characteristicsVariableNLRLMRPLRLDHAll *n*=225NLR≤2.94NLR\>2.94pLMR≤4.74LMR\>4.74pPLR≤133.5PLR\>133.5pLDH≤188.5LDH\>188.5pAge, y0.2960.1690.5660.184 \<531401033755851053511525 ≥53855431454055306520Tumor type0.0260.0910.1310.943 benign443591727386359 well966927395762347917 moderate744925353952225915 poor844716262 others303212121Anatomic stage0.0020.0630.0050.076 0443391725366339 I675116234448195710 II3928111821318336 III624121313139225012 IV154111146987N stage0.0010.0240.0090.053 01481123658901153312325 128151318101513244 236261015212412279 31349946776M0.0080.0510.1460.545 022215765971251596317943 1303301221Initial treatment0.0040.0940.8630.052 surveillance231013149167158 surgery22514755851161445916636Recurrence0.010.6350.0040.235 no1501133765851163412426 yes754431354044315718Vital status0.0000.00100.003 Alive17113140651061343714526 Dead542628351926283618

On Kaplan-Meier analysis, NLR \> 2.94 was associated with inferior OS (log-rank *p* = 0.001), and inferior PFS (log-rank *p* = 0.004) in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}; LMR \> 4.74 was associated with inferior OS (log-rank *p* = 0.001), but not associated with PFS (log-rank *p* = 0.547) in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}; PLR \> 133.5 was associated with inferior OS (log-rank *p* \< 0.001) and inferior PFS (log-rank *p* = 0.001) in Figs. [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}. LDH \< 188.5 was associated with inferior OS (log-rank *p* = 0.004), but not associated with PFS (log-rank *p* = 0.155) in Figs. [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}. Fig. 1KaplanMeier curve of NLR for overall survival (OS)Fig. 2KaplanMeier curve of NLR for progression free survival (PFS)Fig. 3KaplanMeier curve of LMR for overall survival (OS) and 4Fig. 4KaplanMeier curve of LMR for progression free survival (PFS)Fig. 5KaplanMeier curve of PLR for overall survival (OS)Fig. 6KaplanMeier curve of PLR for progression free survival (PFS)Fig. 7KaplanMeier curve of LDH for overall survival (OS)Fig. 8KaplanMeier curve of LDH for progression free survival (PFS)

In univariable analyses, NLR \> 2.94 was associated with inferior OS (HR = 2.967; 95% CI: 1.739--5.064, *p* \< 0.001) and inferior PFS (HR = 1.944; 95% CI: 1.226--3.081,*p* = 0.005); LMR \> 4.74 was associated with inferior OS (HR = 0.394; 95% CI: 0.225--0.689, *p* = 0.001) and not associated with inferior PFS (HR = 0.871; 95% CI: 0.553--1.372,*p* = 0.551); PLR \> 133.5 was associated with inferior OS (HR = 3.439; 95% CI: 2.011--5.881, *p* \< 0.001) and inferior PFS (HR = 2.194; 95% CI: 1.384--3.478,*p* = 0.001); LDH \> 188.5 was associated with inferior OS (HR = 2.252; 95% CI: 1.267--4.002, *p* = 0.006) and not associated with inferior PFS (HR = 1.462; 95% CI: 0.859--2.487,*p* = 0.162).

We performed a multivariate analysis which reveal NLR was not significant independent factors for OS(*p* = 0.516) and PFS(*p* = 0.594); LMR was not associated with OS(*p* = 0.97) and PFS; PLR was significant independent factors for both OS(*p* = 0.001) and PFS(*p* = 0.02); LDH was significant independent factors for OS(*P* = 0.035) but not for PFS. At multivariate analysis, lymph node status (*P* = 0.03) and metastasis status remained significant for OS and PFS as NCCN or EAU Guidelines indicated; However, ages, the tumor type and initial treatment was not significant for OS and PFS in multivariable analyses **(**Table [2](#Tab2){ref-type="table"}**).**Table 2Cox regression model for OS and PFSVariablesOSPFSUnivariableMultivariableUnivariableMultivariableHR95%CIpHR95%CIpHR95%CIpHR95%CIp**Ages** \<53reference1.077-3.1740.026reference1.055-3.9830.035reference0.785-1.9740.352 ≥531.8491.9611.245**Tumor type** benign tumorreference0.002reference0.205reference0.006reference0.135 Well0.970.021-0.4480.3050.054-1.7150.0460.039-0.9700.4050.075-2.186 moderate0.2110.060-0.7370.220.052-0.9380.3320.116-2.0700.510.111-2.336 poor0.4470.130-1.5410.4190.106-1.6550.8680.211-3.7160.8950.201-3.982 others0.5940.130-2.7190.2650.051-1.3780.6460.109-3.9440.3010.043-2.112**Inguinal lymph node** negigitvereference5.243-20.9180.000reference3.224-15.7840.000reference3.096-8.0800.000reference2.198-6.2500.000 positive10.4727.1335.0023.706**Metastasis** 0reference6.637-85.9270.000reference2.223-40.2380.002reference2.484-26.5050.001reference1.184-18.0720.028 123.8819.4588.1144.626**Initial treatment** surveillancereference0.222-0.9370.033reference0.18-1.0060.052reference0.345-1.3070.241 surgery0.4560.4250.671**NLR** low NLRreference1.739-5.0640.000reference0.605-2.7180.516reference1.226-3.0810.005reference0.679-1.9660.594 high NLR2.9671.2831.9441.115**LMR** low LMRreference0.025-0.6890.001reference0.448-2.1640.97reference0.553-1.3720.871 high LMR0.3940.9850.551**PLR** low PLRreference2.011-5.8810.000reference1.644-6.1710.001reference1.384-3.4780.001reference1.104-3.2420.02 high PLR3.4393.1862.1941.892**LDH** low LDHreference1.267-4.0020.006reference1.051-3.8080.035reference0.859-2.4870.162 high LDH2.25221.462

NLR LMR PLR LDH vs inguinal lymph node-negative/positive {#Sec5}
--------------------------------------------------------

In logistic regression analyses, NLR (HR = 2.212; 95% CI: 1.228--3.985,*p* = 0.008), LMR (HR = 0.537; 95% CI: 0.308--0.937,*p* = 0.029), PLR (HR = 2.478; 95% CI:1.365--4.497,*p* = 0.003) was significant corresponded to N stage which divided into the Node-negative group and Node-positive groups, however the LDH (*p* = 0.165) was not associated with the N stage. Meantime we also use Kendall's tau-b method to evaluated the correlations, NLR (Kendall's tau-b = 0.131, *P* = 0.017) LMR (Kendall's tau-b = − 0.109, *P* = 0.046) PLR (Kendall's tau-b = 0.161, *P* = 0.003) were weakly correlated to the N stage. In other words, higher NLR, PLR and lower LMR was more likely to detected pathologically positive inguinal lymph node after ILND. The biomarkers of NLR LMR and PLR could predict the pathological outcomes of ILND.

Discussion {#Sec6}
==========

In recent years, the role of inflammatory factors in cancer development and progression has received more attention. The tumor micro-environment may be associated with systemic inflammation. Several types of cancer have been adopt inflammatory factors in prognostic scores for predict the outcome \[[@CR19]\] and IMDC scores of advanced renal cell carcinoma also added those factors.

Recently, an elevated ratio of peripheral neutrophils-to-lymphocytes (NLR) has been recognized as a poor prognostic indicator in penile cancer, Patients with a high NLR had significantly worse CSS \[[@CR17], [@CR18]\] and OS \[[@CR16]\];Patients with a low LMR had significantly worse RFS and CSS than those with a high LMR \[[@CR18]\].

However, there is no date about the PLR and LDH in penile cancer, this paper aims to collect data from China and conduct comparative analysis of NLR, LMR, PLR and LDH, these bio-markers are critical in guiding clinical management decisions and follow-up strategies.

The incidence of penile cancer itself is very low, so it is difficult to analyze with a large sample size. The incidence of penile cancer is relatively high in China, especially in Yunnan Province, so the sample size of this paper is relatively large.

In addition, it is difficult to judge whether there is lymph node metastasis before ILND, therefore, we also hope to assist in judgment whether there is lymph node metastasis from these indicators, so that we can choose the different surgical approach.

We acknowledge the several limitations to this study including inherent biases associated with its retrospective design, insufficient time to follow-up and population heterogeneity. Besides, more than 20% of the patients were lost to follow-up which may affect the statistical results.

We originally wanted to analyze C-reactive protein (CRP) at the same time. Since the early patients failed to perform CRP testing uniformly, the indicator failed to enter the analysis.

Conclusion {#Sec7}
==========

PLR was significant independent factors for OS and PFS, Ages and LDH was significant independent factors for OS. NLR, LMR, PLR was corresponded to N stage.

NLR

:   Neutrophil-to-lymphocyte ratio

LMR

:   Lymphocyte-to-monocyte ratio

PLR

:   Platelet-to-lymphocyte ratio

LDH

:   Lactate dehydrogenase
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